Combination Therapy with SGLT2 Inhibitors and Tafamidis Improves Outcomes More Than Tafamidis Alone in ATTR Cardiac Amyloidosis

Baba Ali N, Attaripour Esfahani S, Abbas MT et al.

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4358519

doi.org/10.1161/circ.152.suppl_3.4358519